Novelstar Pharmaceuticals Inc.
Nagarjuna R M is an experienced Manager in Analytical Research for Complex Generics, Peptides, ANDA and NDA's, 505 B2, and CBE-30. Nagarjuna R has a background in managing and overseeing method development and validation activities for a variety of dosage forms. Nagarjuna has a Master's degree in Organic Chemistry and a Bachelor's degree in Chemistry and Biology.
This person is not in any teams
Novelstar Pharmaceuticals Inc.
Novelstar Pharmaceuticals Inc., founded in August, 2018, is a Company of Fosun Pharma focusing on the development of special pharmaceutical products of NDA and ANDA with advanced drug delivery systems. Our parent company, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is a leading health and medical industry group in China. Fosun Pharma has a mission to promote human health. Its business covers the whole pharmaceutical industry chain, including drug manufacturing and R & D, medical services, medical device and medical diagnostics, pharmaceutical distribution and retail. Fosun Pharma has a state-of-the-art innovative technology center and an international R & D team. It continuously focuses on innovative research and development in cardiovascular, central nervous system, blood system, metabolism and digestive system, anti-infective and anti-tumor therapeutic fields. Facing the future, Fosun Pharma will adhere to the brand philosophy of “continuing to innovate and enjoy health” and continue to adhere to the development strategy of “endogenous growth, outward expansion and integrated development”, and strive to become the first-class enterprise in the global mainstream medical and health market. Learn more on the FosunPharma website: https://www.fosunpharma.com/en/